NCT05189951

Brief Summary

This study was conducted with 90 patients. The phlebotomy site was wiped with circular motion in the group-I, vertical movement in the group-II, and first vertical and then circular motion in the group-III.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 13, 2022

Completed
Last Updated

January 26, 2022

Status Verified

January 1, 2022

Enrollment Period

11 months

First QC Date

December 21, 2021

Last Update Submit

January 14, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Vein Assessment

    This evaluation has a total of 5 assessment steps, (1) veins are neither visible nor palpable, (2) veins are visible but not palpable, (3) veins are barely visible and palpable, (4) veins are visible and palpable, and (5) veins are clearly visible and easily palpable.

    up to 1 minute after wiping the venipuncture site

  • Change in complications at 72 hours

    The results of evaluations such as complication development and size of the complications. It was evaluated three times at the 24th, 48th and 72nd hours.

    24th, 48th and 72nd hour

Study Arms (3)

circular motion

EXPERIMENTAL

The phlebotomy site was wiped in a circular motion from the center outwards, approximately 5x5 cm wide.

Other: circular motion

vertical motion

EXPERIMENTAL

The phlebotomy site was wiped vertically from top to bottom with a single maneuver.

Other: vertical motion

first vertical then circular motion

EXPERIMENTAL

The phlebotomy site was first vertically wiped from top to bottom with a single maneuver, and then it was wiped in a circular motion from the center to the outside. Different swabs were used in both wipes.

Other: circular+vertical motion

Interventions

The phlebotomy site was wiped in a circular motion from the center outwards, approximately 5x5 cm wide.

circular motion

The phlebotomy site was wiped vertically from top to bottom with a single maneuver.

vertical motion

The phlebotomy site was first vertically wiped from top to bottom with a single maneuver, and then it was wiped in a circular motion from the center to the outside.

first vertical then circular motion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • who are over 18 years old,
  • without any psychiatric diseases,
  • without vision or hearing problems,
  • hospitalized in the internal medicine clinic,
  • with platelet counts of 200 000 / mm³ and above,
  • cc of blood is ordered for lab test and
  • individuals who volunteered to participate in the study

You may not qualify if:

  • having a local or systemic infection,
  • having vascular disease,
  • having an immunopathological problem,
  • scarring, psoriasis, active dermatitis in the phlebotomy site,
  • having peripheral nerve disease,
  • having peripheral neuropathy,
  • patients with coagulation disorder,
  • individuals who don't volunteered to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes University

Kayseri, 38039, Turkey (Türkiye)

Location

Study Officials

  • Sevda Korkut

    TC Erciyes University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor

Study Record Dates

First Submitted

December 21, 2021

First Posted

January 13, 2022

Study Start

July 1, 2020

Primary Completion

May 28, 2021

Study Completion

May 28, 2021

Last Updated

January 26, 2022

Record last verified: 2022-01

Locations